These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9147283)

  • 1. In vitro kinetics of drug release and pulmonary retention of microencapsulated antibiotic in liposomal formulations in relation to the lipid composition.
    Beaulac C; Clement-Major S; Hawari J; Lagace J
    J Microencapsul; 1997; 14(3):335-48. PubMed ID: 9147283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection.
    Beaulac C; Clément-Major S; Hawari J; Lagacé J
    Antimicrob Agents Chemother; 1996 Mar; 40(3):665-9. PubMed ID: 8851590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced bactericidal potency of nanoliposomes by modification of the fusion activity between liposomes and bacterium.
    Ma Y; Wang Z; Zhao W; Lu T; Wang R; Mei Q; Chen T
    Int J Nanomedicine; 2013; 8():2351-60. PubMed ID: 23847417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion between fluid liposomes and intact bacteria: study of driving parameters and in vitro bactericidal efficacy.
    Wang Z; Ma Y; Khalil H; Wang R; Lu T; Zhao W; Zhang Y; Chen J; Chen T
    Int J Nanomedicine; 2016; 11():4025-36. PubMed ID: 27574430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro bactericidal efficacy of sub-MIC concentrations of liposome-encapsulated antibiotic against gram-negative and gram-positive bacteria.
    Beaulac C; Sachetelli S; Lagace J
    J Antimicrob Chemother; 1998 Jan; 41(1):35-41. PubMed ID: 9511035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosolization of low phase transition temperature liposomal tobramycin as a dry powder in an animal model of chronic pulmonary infection caused by Pseudomonas aeruginosa.
    Beaulac C; Sachetelli S; Lagacé J
    J Drug Target; 1999; 7(1):33-41. PubMed ID: 10614813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling the size and shape of liposomal ciprofloxacin nanocrystals by varying the lipid bilayer composition and drug to lipid ratio.
    Li T; Clulow AJ; Nowell CJ; Hawley A; Cipolla D; Rades T; Boyd BJ
    J Colloid Interface Sci; 2019 Nov; 555():361-372. PubMed ID: 31398564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.
    Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M
    Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of drug release from liposomal formulations in ocular fluid.
    Jafari MR; Jones AB; Hikal AH; Williamson JS; Wyandt CM
    Drug Deliv; 1998; 5(4):227-38. PubMed ID: 19569989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia.
    Halwani M; Mugabe C; Azghani AO; Lafrenie RM; Kumar A; Omri A
    J Antimicrob Chemother; 2007 Oct; 60(4):760-9. PubMed ID: 17673475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations.
    Beck-Broichsitter M; Rieger M; Reul R; Gessler T; Seeger W; Schmehl T
    Eur J Pharm Biopharm; 2013 May; 84(1):106-14. PubMed ID: 23262166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, properties and the effects of free and liposomal tobramycin on siderophore production by Pseudomonas aeruginosa.
    Poyner EA; Alpar HO; Brown MR
    J Antimicrob Chemother; 1994 Jul; 34(1):43-52. PubMed ID: 7961214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary liposomal formulations encapsulated procaterol hydrochloride by a remote loading method achieve sustained release and extended pharmacological effects.
    Tahara K; Tomida H; Ito Y; Tachikawa S; Onodera R; Tanaka H; Tozuka Y; Takeuchi H
    Int J Pharm; 2016 May; 505(1-2):139-46. PubMed ID: 27012982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
    Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
    Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of bovine thyroid peroxidase in liposomes.
    Manjon A; Garcia-Borron JC; Lozano JA; Iborra JL
    Chem Phys Lipids; 1984 Mar; 34(3):237-44. PubMed ID: 6713599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations.
    Johnston MJ; Semple SC; Klimuk SK; Edwards K; Eisenhardt ML; Leng EC; Karlsson G; Yanko D; Cullis PR
    Biochim Biophys Acta; 2006 Jan; 1758(1):55-64. PubMed ID: 16487476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal (MLV) polymyxin B: physicochemical characterization and effect of surface charge and drug association.
    Lawrence SM; Alpar HO; McAllister SM; Brown MR
    J Drug Target; 1993; 1(4):303-10. PubMed ID: 8069572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DSC and NMR spectroscopic studies of the interaction between camphorated phenol and phospholipid liposomes.
    Fujisawa S; Kadoma Y; Ito S
    Dent Mater J; 1998 Dec; 17(4):314-20. PubMed ID: 10219145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the pulmonary and systemic immunogenicity of Fluidosomes, a fluid liposomal-tobramycin formulation for the treatment of chronic infections in lungs.
    Sachetelli S; Beaulac C; Riffon R; Lagacé J
    Biochim Biophys Acta; 1999 Aug; 1428(2-3):334-40. PubMed ID: 10434052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.